Bank of Montreal
INDV icon

Bank of Montreal’s Indivior Pharmaceuticals INDV Stock Holding History

Bank of Montreal’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Sell
8,581
-829
-9% -$30.1K ﹤0.01% 2676
2026
Q1 		$287K Buy
9,410
+1,183
+14% +$39.1K ﹤0.01% 2707
2025
Q4 		$295K Buy
+8,227
New +$251K ﹤0.01% 2597
2025
Q3 		– Sell
-901
Closed -$361K – 3670
2025
Q2 		$361K Buy
901
+37
+4% +$431 ﹤0.01% 2475
2025
Q1 		$810K Hold
864
– – ﹤0.01% 1918
2024
Q4 		$315K Sell
864
-11,096
-93% -$114K ﹤0.01% 2515
2024
Q3 		$4.66M Buy
11,960
+2,217
+23% +$26K ﹤0.01% 1353
2024
Q2 		$3.6M Sell
9,743
-1,898,554
-99% -$34.3M ﹤0.01% 1401
2024
Q1 		$704M Buy
1,908,297
+1,746,740
+1,081% +$32.8M 0.21% 58
2023
Q4 		$60.2M Buy
+161,557
New +$2.87M 0.02% 420

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's INDV Position: Q2 2026 in Review

Bank of Montreal reduced its Indivior Pharmaceuticals (INDV) stake by 8.8% in Q2 2026, selling an estimated $30.1K and leaving 8,581 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

Bank of Montreal first reported a position in INDV in Q4 2023 and has held it in 10 quarters since. The position peaked at $704M in Q1 2024. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Bank of Montreal held 8,581 shares of Indivior Pharmaceuticals worth $352K as of Q2 2026.
  • Bank of Montreal sold 829 Indivior Pharmaceuticals shares in Q2 2026, an estimated $30.1K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2676 holding.
  • Bank of Montreal first reported a position in Indivior Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Bank of Montreal's Indivior Pharmaceuticals position peaked at $704M in Q1 2024.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.